Genomic Tests
Genomic Tests Price
These tests collectively offer a comprehensive approach to genetic health assessment, from cancer prevention to personalised medication management, providing valuable insights for individuals and healthcare providers alike.
Hereditary Cancer Prevention
Predisposition Cancer Scoring (12 cancer types): Evaluates genetic markers associated with increased risk for 12 common-
Breast cancer
-
Lung cancer (including bronchus)
-
Prostate cancer
-
Colorectal cancer (colon and rectal)
-
Melanoma (skin cancer)
-
Bladder cancer
-
Non-Hodgkin’s lymphoma
-
Kidney cancer (renal cell and renal pelvis)
-
Endometrial cancer (uterine)
-
Leukemia
-
Pancreatic cancer
-
Thyroid cancer
Comprehensive Exome-based Screening
Analyses the entire coding region of DNA to detect mutations in genes linked to hereditary cancer syndromes. This thorough assessment provides a comprehensive view of genetic cancer risk, enabling personalised prevention strategies.-
Whole Exome Analysis of DNA's entire coding region
-
Detection of mutations across all known hereditary cancer syndromes
-
Provides the most thorough assessment of genetic cancer risk
-
Enables personalised prevention and surveillance strategies
-
Identifies risk for rare and common hereditary cancers
-
Includes detailed geneticist report and interpretation
-
Performed in CAP-accredited and ISO-certified laboratories
Hereditary Disease Prevention
Predisposition Risk Scoring (15+ conditions): Assesses genetic risk factors for multiple common hereditary diseases, such as heart disease, diabetes, and certain cancers. This test allows for early intervention and lifestyle modifications, potentially preventing or delaying disease onset.-
Assesses genetic risk factors for 15+ common hereditary diseases
-
Includes risk for major conditions such as Heart Disease, Diabetes, and certain cancers.
-
Enables early intervention and crucial lifestyle modifications.
-
Provides insights for preventing or delaying disease onset.
-
Utilises advanced scoring models for proactive health planning.
-
Aids clinicians in determining enhanced surveillance protocols.
Diagnostic Exome
Examines all protein-coding genes in the genome to identify genetic variants causing rare inherited disorders. This test is particularly useful for diagnosing complex or undiagnosed genetic conditions, offering insights into rare diseases.-
Examines all protein-coding genes in the entire human genome.
-
Primary use is to identify genetic variants causing rare inherited disorders.
-
Crucial for diagnosing complex or previously undiagnosed genetic conditions.
-
Provides in-depth insights for obscure and rare diseases.
-
Offers a comprehensive solution when targeted panel testing is inconclusive.
-
Results are essential for final diagnosis and guiding management strategies.
Autism CGH Array
Uses comparative genomic hybridisation to detect chromosomal abnormalities, including deletions and duplications, associated with autism spectrum disorders. This test helps identify specific genetic causes of autism, aiding in diagnosis and treatment planning.-
Utilises Comparative Genomic Hybridisation (CGH) technology.
-
Detects chromosomal abnormalities, including significant deletions and duplications.
-
Specifically targets genetic causes associated with Autism Spectrum Disorders (ASD).
-
Helps to identify specific genetic causes of a patient's autism.
-
Crucial for aiding in definitive diagnosis and personalised treatment planning.
-
Offers insights when single gene sequencing may be inconclusive.
Autism – Exome-based
Provides a comprehensive analysis of all protein-coding genes to identify mutations associated with autism spectrum disorders. This test offers a deeper understanding of the genetic factors contributing to autism, potentially leading to more targeted interventions.-
Provides a comprehensive analysis of all protein-coding genes (Exome).
-
Specifically designed to identify single-gene mutations associated with Autism Spectrum Disorders (ASD).
-
Offers a deeper understanding of the complex genetic factors contributing to autism.
-
Results can potentially lead to more targeted and personalised interventions and management.
-
Utilises NGS technology for high accuracy and sensitivity.
-
Highly recommended when standard genetic testing yields inconclusive results.
Carrier Screening
Tests for genetic mutations that could be passed on to children, including those causing cystic fibrosis, GJB2-related hearing loss, and Tay-Sachs disease. This screening is essential for family planning, allowing couples to make informed decisions about reproduction-
Tests for genetic mutations that could be passed on to children.
-
Covers an extensive panel of over 400 hereditary conditions.
-
Includes major conditions such as Cystic Fibrosis, GJB2-related hearing loss, and Tay-Sachs disease.
-
Essential screening for family planning and pre-conception assessment.
-
Enables couples to make informed decisions about reproduction and genetic risk.
-
Utilises advanced sequencing to provide high-accuracy carrier status.
Pharmacogenetics Test
Analyses genetic variations that influence how an individual metabolises and responds to different medications. This test helps healthcare providers optimise drug selection and dosing, reducing adverse effects and improving treatment efficacy. It is particularly useful for tailoring treatments in various medical fields.-
Analyses genetic variations that influence drug metabolism and response.
-
Helps healthcare providers optimise drug selection and dosing.
-
Crucial for reducing adverse effects and improving treatment efficacy.
-
Particularly useful for tailoring treatments in various medical fields (e.g., oncology, psychiatry).
-
Supports personalised medicine by ensuring the right dose for the right patient.
-
Provides essential information to avoid drugs that may be ineffective or harmful.
The Critical Role of Advanced Genomic Testing
In modern healthcare, Genomic Tests are absolutely fundamental to personalised medicine, offering crucial insight into an individual’s predisposition to diseases, their drug responsiveness, and the definitive diagnosis of complex conditions. At London Genetics, we offer a comprehensive suite of Advanced Genomic Tests, ensuring every patient benefits from the highest level of diagnostic precision available today.
Next Generation Sequencing (NGS): The Core Technology
All of our Genomic Tests are underpinned by Next Generation Sequencing (NGS) technology. NGS marks a significant shift from conventional sequencing methods, allowing us to read millions of DNA fragments simultaneously. This high-throughput capability bestows several key advantages upon our Genomic Tests, fundamentally transforming diagnostic capability and precision.
NGS provides **unrivalled accuracy** and sensitivity. It enables the detection of minute, **subtle genetic mutations**—including single nucleotide variations (SNVs)—that would ordinarily be missed by older sequencing technologies. This is paramount for the diagnosis of rare or low-frequency somatic mutations, particularly in early-stage oncology.
The technology offers **comprehensive analysis** across the entire genome. We have the capacity to examine hundreds of genes concurrently via targeted panels, or the entire protein-coding region through **Whole Exome Sequencing (WES)**. This comprehensive approach ensures no vital genetic information is overlooked, even in the most complex cases.
NGS workflows have been **optimised** to deliver results with an expedited **Turnaround Time (TAT)**. While the scope is vast, the process is streamlined to meet **clinical urgency**—from rapid exome sequencing in urgent **paediatric** cases to ensuring timely data for reproductive and metabolic health management.
NGS: The standard for precision. By utilising Next Generation Sequencing, London Genetics ensures that your diagnostic results are reliable, comprehensive, and suitable for driving personalised treatment decisions.
Upholding Global Standards: Quality and Accreditation
Confidence in the results is paramount in genetic testing. Our rigorous commitment to quality is validated by international regulatory bodies:
CAP and ISO Certification: All tests are processed exclusively in CAP-accredited and ISO-certified laboratories. This certification guarantees adherence to the most stringent international standards for quality control, technical proficiency, and robust clinical interpretation.
International Partnerships: We work closely with global leaders in Genomic Tests, including renowned entities such as Arcensus and Igenomix, to ensure that our clinical interpretation services are based upon the latest cutting-edge research and expertise worldwide.
Patient Convenience and Data Security
We appreciate the importance of a straightforward and convenient testing experience whilst maintaining absolute security for your sensitive genetic information.
Flexible Sample Collection:
Depending on the specific Genomic Test required and your personal preference, samples can be collected easily:
Convenient At-Home Collection: Utilise simple saliva kits to collect the sample from the comfort and privacy of your own home (Note the British spelling for ‘home’ context).
In-Clinic Blood Draw: A quick and straightforward blood draw performed by our experienced staff at the clinic.
Full GDPR Compliance:
Our entire testing process is fully GDPR-compliant, ensuring the highest level of confidentiality and security for all patient genetic data. We guarantee your sensitive information is handled and protected in line with the European Union’s exacting privacy regulations.
Optimised Turnaround Time (TAT) for Clinical Urgency
We recognise that the swiftness of a **Genomic Test** result is often critical, particularly in time-sensitive clinical scenarios. At London Genetics, we provide an **Optimised Turnaround Time (TAT)** that is precisely tailored to the clinical urgency and specific disease category, ensuring timely clinical action.
See how our TAT is customised to meet your urgent clinical needs.
TAT: A measure of our commitment. Our optimised Turnaround Time ensures that valuable **Genomic Test** data is delivered when it matters most, supporting the transition from diagnosis to **personalised treatment**.
Detailed Reporting and Expert Post-Test Counselling
The analysis of our Genomic Tests is followed by an established interpretation and support process:
Specialist Review: Every result is thoroughly reviewed and signed off by a Specialist Geneticist.
Detailed Clinical Report: A comprehensive report is provided, clearly setting out the findings and their clinical implications.
Post-Test Counselling: We offer essential post-test counselling sessions (Note: Counselling is the preferred British spelling) to help you fully understand your results and integrate this vital information into your personalised treatment (Note: Personalised is the British spelling) and surveillance plans.
Ready to Access Precision Diagnostics?
Our comprehensive approach includes post-test counselling and detailed reports, ensuring your results provide not just data, but actionable insights to inform your personalised treatment and health surveillance plans.
We are dedicated to supporting both patients and clinicians with reliable, timely, and expert Genomic Tests, specifically designed for the complexities of modern medicine.
Take the next step in your health journey. Contact London Genetics today to discuss your particular testing requirements and discover how our specialist services can fully support your health and diagnostic journey.
Book a Consultation